Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?
about
Prevention and treatment of bone changes associated with exposure to glucocorticoidsCyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Bone health issues in sarcoidosis.Bisphosphonates and glucocorticoid-induced osteoporosis: cons.Inflammatory rheumatic disorders and bone.Clinical role of bisphosphonate therapy.Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis.One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapyCorticosteroid-induced osteoporosis: an update for dermatologists.Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force.Effects of tibolone on osteoarthritis in ovariectomized rats: association with nociceptive pain behaviour.Glucocorticoids, Inflammation and Bone.Sclerostin Blockade-A Dual Mode of Action After All?The conundrum of glucocorticoid-induced osteoporosis
P2860
Q26861474-3218FCB4-961F-443A-9C02-1F125738DB12Q34765802-0756FC82-42F7-42FC-A9C6-A0B281EF2FDFQ35850086-0C880344-5725-4C8B-BC38-D8310E833E1CQ35882427-E712F667-FEB3-4EF7-8AB1-80BAA1E91E32Q35918747-8C308A16-8576-4679-A652-E0139FC20688Q36311593-7EE6C8D8-524E-4F4F-ACAF-F56D81A88606Q36873339-7789619D-A5F9-42A6-9C87-C076475AADD6Q37251693-3A9C33E7-651A-4A1C-96F4-58EEAD6DAA23Q37990943-F690F7A7-AFE9-4DEA-9839-EC6F312D21ECQ38073889-49CC8A8F-B084-4A4F-945D-37627274A789Q38757421-B05E71F4-CD74-4F89-8672-FCAF57CBF6B7Q46667175-CF691C23-D6C4-4A3E-97EE-E053E894FBAEQ50128187-55A7AB48-91CB-4FB3-97B8-D45406CF22C5Q54035461-2F64CBB3-CE86-4810-9BE5-313B37605118Q58085028-73D1F530-57FC-4F1C-A33E-64085EECA7E9
P2860
Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Should bisphosphonates be used ...... orticoid-induced osteoporosis?
@ast
Should bisphosphonates be used ...... orticoid-induced osteoporosis?
@en
Should bisphosphonates be used ...... orticoid-induced osteoporosis?
@nl
type
label
Should bisphosphonates be used ...... orticoid-induced osteoporosis?
@ast
Should bisphosphonates be used ...... orticoid-induced osteoporosis?
@en
Should bisphosphonates be used ...... orticoid-induced osteoporosis?
@nl
prefLabel
Should bisphosphonates be used ...... orticoid-induced osteoporosis?
@ast
Should bisphosphonates be used ...... orticoid-induced osteoporosis?
@en
Should bisphosphonates be used ...... orticoid-induced osteoporosis?
@nl
P2860
P356
P1476
Should bisphosphonates be used ...... orticoid-induced osteoporosis?
@en
P2093
Kenneth G Saag
Margaret P Seton
P2860
P304
P356
10.1002/ART.30135
P577
2011-02-01T00:00:00Z